Vital Innovations Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Vital Innovations Holdings şirketinin toplam hissedar öz sermayesi CN¥494.0M ve toplam borcu CN¥28.0M olup, bu da borç-öz sermaye oranını 5.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥625.4M ve CN¥131.4M dir.

Anahtar bilgiler

5.7%

Borç/özkaynak oranı

CN¥27.97m

Borç

Faiz karşılama oranı	n/a
Nakit	CN¥12.47m
Eşitlik	CN¥494.00m
Toplam yükümlülükler	CN¥131.44m
Toplam varlıklar	CN¥625.43m

Son finansal sağlık güncellemeleri

Recent updates

There's Reason For Concern Over Vital Innovations Holdings Limited's (HKG:6133) Price

Nov 24

Is Vital Innovations Holdings (HKG:6133) A Risky Investment?

Sep 05

Subdued Growth No Barrier To Vital Innovations Holdings Limited's (HKG:6133) Price

Jun 26

Pinning Down Vital Innovations Holdings Limited's (HKG:6133) P/S Is Difficult Right Now

Mar 21

We Think Vital Innovations Holdings (HKG:6133) Has A Fair Chunk Of Debt

Dec 06

Vital Innovations Holdings Limited's (HKG:6133) Subdued P/S Might Signal An Opportunity

Aug 22

Is Vital Innovations Holdings (HKG:6133) Using Debt Sensibly?

Sep 16

Is Vital Innovations Holdings (HKG:6133) Using Debt In A Risky Way?

Dec 24

Is Vital Innovations Holdings (HKG:6133) Using Debt In A Risky Way?

Sep 08

What Type Of Returns Would Vital Innovations Holdings'(HKG:6133) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 14

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 6133 'nin kısa vadeli varlıkları ( CN¥624.4M ) kısa vadeli yükümlülüklerini ( CN¥131.1M ) aşıyor.

Uzun Vadeli Yükümlülükler: 6133 şirketinin kısa vadeli varlıkları ( CN¥624.4M ) uzun vadeli yükümlülüklerini ( CN¥342.0K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 6133 'nin net borç/öz sermaye oranı ( 3.1% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 6133 şirketinin borç/öz sermaye oranı son 5 yılda 2.6% seviyesinden 5.7% seviyesine yükseldi.

Borç Kapsamı: 6133 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: 6133 şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.

Vital Innovations Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Vital Innovations Holdings (HKG:6133) A Risky Investment?

We Think Vital Innovations Holdings (HKG:6133) Has A Fair Chunk Of Debt

Is Vital Innovations Holdings (HKG:6133) Using Debt Sensibly?

Is Vital Innovations Holdings (HKG:6133) Using Debt In A Risky Way?

Is Vital Innovations Holdings (HKG:6133) Using Debt In A Risky Way?

Recent updates

There's Reason For Concern Over Vital Innovations Holdings Limited's (HKG:6133) Price

Less than half of directors are independent

First half 2024 earnings released: CN¥0.011 loss per share (vs CN¥0.01 loss in 1H 2023)

Is Vital Innovations Holdings (HKG:6133) A Risky Investment?

Vital Innovations Holdings Limited to Report First Half, 2024 Results on Aug 29, 2024

Subdued Growth No Barrier To Vital Innovations Holdings Limited's (HKG:6133) Price

Vital Innovations Holdings Limited, Annual General Meeting, Jun 27, 2024

Full year 2023 earnings released: CN¥0.024 loss per share (vs CN¥0.021 loss in FY 2022)

Less than half of directors are independent

Vital Innovations Holdings Limited to Report Fiscal Year 2023 Results on May 16, 2024

Pinning Down Vital Innovations Holdings Limited's (HKG:6133) P/S Is Difficult Right Now

Vital Innovations Holdings Limited to Report Fiscal Year 2023 Final Results on Mar 26, 2024

We Think Vital Innovations Holdings (HKG:6133) Has A Fair Chunk Of Debt

First half 2023 earnings released: CN¥0.01 loss per share (vs CN¥0.01 loss in 1H 2022)

New major risk - Revenue and earnings growth

Vital Innovations Holdings Limited's (HKG:6133) Subdued P/S Might Signal An Opportunity

Vital Innovations Holdings Limited to Report First Half, 2023 Results on Aug 30, 2023

Less than half of directors are independent

Is Vital Innovations Holdings (HKG:6133) Using Debt Sensibly?

First half 2022 earnings released: CN¥0.01 loss per share (vs CN¥0.011 loss in 1H 2021)

Vital Innovations Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022

Less than half of directors are independent

Full year 2021 earnings released: CN¥0.024 loss per share (vs CN¥0.12 loss in FY 2020)

Is Vital Innovations Holdings (HKG:6133) Using Debt In A Risky Way?

Is Vital Innovations Holdings (HKG:6133) Using Debt In A Risky Way?

First half 2021 earnings released: CN¥0.011 loss per share (vs CN¥0.084 loss in 1H 2020)

Full year 2020 earnings released: CN¥0.12 loss per share (vs CN¥0.007 loss in FY 2019)

Vital Innovations Holdings Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day low: HK$0.37

Vital Innovations Holdings Limited Announces Appointment of Independent Non-Executive Directors, and Change of Composition of Board Committees

What Type Of Returns Would Vital Innovations Holdings'(HKG:6133) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

New 90-day high: HK$0.35

Vital Innovations Holdings Limited Announces Director and Committee Changes

New 90-day low: HK$0.22

First half earnings released

First half earnings released

New 90-day low - HK$0.29

Vital Innovations Holdings Limited to Report First Half, 2020 Results on Aug 31, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin